Format

Send to:

Choose Destination
See comment in PubMed Commons below
Transl Neurosci. 2013 Mar 1;4(1):46-58.

The Role of Neurotrophins in Major Depressive Disorder.

Author information

  • 1Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA ; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.

Abstract

Neurotrophins and other growth factors have been advanced as critical modulators of depressive behavior. Support for this model is based on analyses of knockout and transgenic mouse models, human genetic studies, and screens for gene products that are regulated by depressive behavior and/or antidepressants. Even subtle alteration in the regulated secretion of brain-derived neurotrophic factor (BDNF), for example, due to a single nucleotide polymorphism (SNP)-encoded Val-Met substitution in proBDNF that affects processing and sorting, impacts behavior and cognition. Alterations in growth factor expression result in changes in neurogenesis as well as structural changes in neuronal cytoarchitecture, including effects on dendritic length and spine density, in the hippocampus, nucleus accumbens, and prefrontal cortex. These changes have the potential to impact the plasticity and stability of synapses in the CNS, and the complex brain circuitry that regulates behavior. Here we review the role that neurotrophins play in the modulation of depressive behavior, and the downstream signaling targets they regulate that potentially mediate these behavioral pro-depressant and antidepressant effects.

KEYWORDS:

Antidepressant; Arc; Brain-Derived Neurotrophic Factor (BDNF); Depression; Ketamine; Nerve Growth Factor (NGF); Neuritin; Neurtrophin-3 (NT-3); Trk; VGF

PMID:
23691270
[PubMed]
PMCID:
PMC3656715
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk